Stryker Corporation $SYK Shares Purchased by AMI Investment Management Inc.

AMI Investment Management Inc. boosted its position in Stryker Corporation (NYSE:SYK) by 4.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,079 shares of the medical technology company’s stock after acquiring an additional 437 shares during the quarter. Stryker accounts for about 1.1% of AMI Investment Management Inc.’s holdings, making the stock its 25th biggest holding. AMI Investment Management Inc.’s holdings in Stryker were worth $4,383,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in SYK. Sachetta LLC lifted its stake in Stryker by 58.7% during the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares during the last quarter. Goodman Advisory Group LLC purchased a new stake in Stryker during the first quarter worth approximately $32,000. City Holding Co. lifted its stake in Stryker by 528.6% during the first quarter. City Holding Co. now owns 88 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 74 shares during the last quarter. Ridgewood Investments LLC lifted its stake in Stryker by 48.4% during the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock worth $36,000 after purchasing an additional 30 shares during the last quarter. Finally, Ransom Advisory Ltd purchased a new stake in Stryker during the first quarter worth approximately $37,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 200,000 shares of the company’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This represents a 5.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Viju Menon sold 500 shares of the company’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. This represents a 3.84% decrease in their position. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Wall Street Analyst Weigh In

SYK has been the subject of several recent analyst reports. Wall Street Zen cut Stryker from a “buy” rating to a “hold” rating in a research note on Friday, September 26th. Truist Financial set a $415.00 price objective on Stryker and gave the company a “hold” rating in a research note on Monday, August 4th. Rothschild Redb upgraded Stryker to a “hold” rating in a research note on Thursday, September 18th. Evercore ISI reduced their price objective on Stryker from $418.00 to $410.00 and set an “outperform” rating for the company in a research note on Tuesday. Finally, Redburn Partners set a $420.00 price objective on Stryker in a research note on Thursday, September 18th. Fifteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $430.10.

Stryker Trading Up 1.7%

NYSE:SYK opened at $375.35 on Thursday. The firm has a market cap of $143.50 billion, a P/E ratio of 49.72, a PEG ratio of 2.66 and a beta of 0.94. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. The stock’s 50 day simple moving average is $380.99 and its 200-day simple moving average is $378.83. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.07 by $0.06. The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Equities analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. Stryker’s payout ratio is presently 44.50%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.